Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIOngoingD-0197-2026

Drug recall · December 10, 2025

Phytonadione Injectable Emulsion recall

Why: Failed Stability Specifications: Observed OOS results: eg results for colour index

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Phytonadione Injectable Emulsion, USP 10mg/mL, 10x1 mL Single-Dose Vial/carton, Rx Only, Mfd. by: Cipla Ltd. India At M/s Immacule Lifesciences PVT. Ltd. India. Mfd. for: Cipla USA, Inc. Warren, NJ 07059. Vial NDC# 69097-708-31; Carton NDC 69097-708-96

Lots / codes

Batch # PH0072404A, PH0082404A, Exp. Date December 31, 2025

Quantity
4,438 10x1mL cartons
Company
Cipla Limited, Pithampur, District Dhar
Distribution
Nationwide in the USA
Initiated
October 31, 2025 · Voluntary: Firm initiated
Classified
November 28, 2025
Reported
December 10, 2025

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.